18.01.2013 13:50 Uhr, Quelle: Wallstreet online

Novartis receives positive CHMP opinion for Ilaris® to treat patients whose acute gouty arthritis cannot be managed with standard of care

Novartis International AG / Novartis receives positive CHMP opinion for Ilaris® to treat patients whose acute gouty arthritis cannot be managed with standard of care . Processed and transmitted by Thomson Reuters ONE. The issuer is solely …

Weiterlesen bei Wallstreet online

Digg del.icio.us Facebook email MySpace Technorati Twitter

JustMac.info © Thomas Lohner - Impressum - Datenschutz